Tags

Type your tag names separated by a space and hit enter

Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients.
Eur Urol. 2004 Jul; 46(1):42-9.EU

Abstract

OBJECTIVE

With a shift in prostate cancer stage and a majority of patients operated nowadays with PSA levels <10 ng/ml, rates of seminal vesicle (SV) invasion found on radical prostatectomy specimens have decreased as compared to historical data. Since SV-sparing surgery may possibly have an influence on post-operative erectile dysfunction and urinary recovery, we tried to determine which patients could be safely spared SV excision during radical prostatectomy.

MATERIAL AND METHODS

We used preoperative data from 1283 patients operated by radical retropubic prostatectomy--777 with serum PSA <10.0 ng/ml--to predict SV invasion on final pathological examination. Variables analyzed included age, digital rectal examination, serum PSA, biopsy Gleason score and percentage of biopsy cores invaded by prostate cancer. Statistical analysis included univariate, multivariate logistic regression analysis and receiver operating characteristic (ROC) curves.

RESULTS

Out of 1283 patients, 137 (10.6%) had SV involvement, 41/777 (5.2%) with PSA <10.0 ng/ml, 16.1% in the 10-20 ng/ml range and 26.2% when PSA was >20 ng/ml. Percentage of biopsies affected by prostate cancer and biopsy Gleason score were significant predictors of SV invasion in multivariate analysis, both in the entire population and in the subset of patients with PSA <10.0 ng/ml (p < 0.0001). Probability graphs created for patients with PSA <10 ng/ml indicate a risk of seminal invasion <5% when Gleason score on biopsy is <7 or when the percentage of biopsies affected by cancer is <50%.

CONCLUSIONS

Resection of SV might not be "oncologically" necessary in all patients undergoing RP when PSA levels are below 10 ng/ml except when biopsy Gleason score is > or =7 or when more than 50% of prostate biopsy cores show cancer involvement. SV-sparing surgery could be prospectively compared to standard retropubic prostatectomy in selected individuals analyzing potential benefits on erectile function and urinary continence.

Authors+Show Affiliations

Department of Urology, Erasme Hospital, University Clinics of Brussels, 808 route de Lennik, B-1070 Brussels, Belgium. azlotta@ulb.ac.beNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study

Language

eng

PubMed ID

15183546

Citation

Zlotta, Alexandre R., et al. "Is Seminal Vesicle Ablation Mandatory for All Patients Undergoing Radical Prostatectomy? a Multivariate Analysis On 1283 Patients." European Urology, vol. 46, no. 1, 2004, pp. 42-9.
Zlotta AR, Roumeguère T, Ravery V, et al. Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients. Eur Urol. 2004;46(1):42-9.
Zlotta, A. R., Roumeguère, T., Ravery, V., Hoffmann, P., Montorsi, F., Türkeri, L., Dobrovrits, M., Scattoni, V., Ekane, S., Bollens, R., Vanden Bossche, M., Djavan, B., Boccon-Gibod, L., & Schulman, C. C. (2004). Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients. European Urology, 46(1), 42-9.
Zlotta AR, et al. Is Seminal Vesicle Ablation Mandatory for All Patients Undergoing Radical Prostatectomy? a Multivariate Analysis On 1283 Patients. Eur Urol. 2004;46(1):42-9. PubMed PMID: 15183546.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients. AU - Zlotta,Alexandre R, AU - Roumeguère,Thierry, AU - Ravery,Vincent, AU - Hoffmann,Paul, AU - Montorsi,Francesco, AU - Türkeri,Levent, AU - Dobrovrits,Michael, AU - Scattoni,Vincenzo, AU - Ekane,Samuel, AU - Bollens,Renaud, AU - Vanden Bossche,Marc, AU - Djavan,Bob, AU - Boccon-Gibod,Laurent, AU - Schulman,Claude C, AU - ,, PY - 2004/03/30/accepted PY - 2004/6/9/pubmed PY - 2004/10/27/medline PY - 2004/6/9/entrez SP - 42 EP - 9 JF - European urology JO - Eur Urol VL - 46 IS - 1 N2 - OBJECTIVE: With a shift in prostate cancer stage and a majority of patients operated nowadays with PSA levels <10 ng/ml, rates of seminal vesicle (SV) invasion found on radical prostatectomy specimens have decreased as compared to historical data. Since SV-sparing surgery may possibly have an influence on post-operative erectile dysfunction and urinary recovery, we tried to determine which patients could be safely spared SV excision during radical prostatectomy. MATERIAL AND METHODS: We used preoperative data from 1283 patients operated by radical retropubic prostatectomy--777 with serum PSA <10.0 ng/ml--to predict SV invasion on final pathological examination. Variables analyzed included age, digital rectal examination, serum PSA, biopsy Gleason score and percentage of biopsy cores invaded by prostate cancer. Statistical analysis included univariate, multivariate logistic regression analysis and receiver operating characteristic (ROC) curves. RESULTS: Out of 1283 patients, 137 (10.6%) had SV involvement, 41/777 (5.2%) with PSA <10.0 ng/ml, 16.1% in the 10-20 ng/ml range and 26.2% when PSA was >20 ng/ml. Percentage of biopsies affected by prostate cancer and biopsy Gleason score were significant predictors of SV invasion in multivariate analysis, both in the entire population and in the subset of patients with PSA <10.0 ng/ml (p < 0.0001). Probability graphs created for patients with PSA <10 ng/ml indicate a risk of seminal invasion <5% when Gleason score on biopsy is <7 or when the percentage of biopsies affected by cancer is <50%. CONCLUSIONS: Resection of SV might not be "oncologically" necessary in all patients undergoing RP when PSA levels are below 10 ng/ml except when biopsy Gleason score is > or =7 or when more than 50% of prostate biopsy cores show cancer involvement. SV-sparing surgery could be prospectively compared to standard retropubic prostatectomy in selected individuals analyzing potential benefits on erectile function and urinary continence. SN - 0302-2838 UR - https://www.unboundmedicine.com/medline/citation/15183546/Is_seminal_vesicle_ablation_mandatory_for_all_patients_undergoing_radical_prostatectomy_A_multivariate_analysis_on_1283_patients_ DB - PRIME DP - Unbound Medicine ER -